U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06907563) titled 'Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)' on March 26.
Brief Summary: The rational to conduct the LOVE study builds on the lack of available data on outcomes in steatotic liver disease in well characterized patients over a time frame of several years. At current limited data on liver-specific and overall outcome in patients with MASLD, MetALD and ALD are available. Liver histology is the only accepted surrogate to reasonably likely predict outcomes in patients with non-cirrhotic liver disease and is currently used in regulatory trials. To overcome the limitations of liver biopsy and use validated non-in...